Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
Penelope GrayHanna KannVille N PimenoffTiina ErikssonTapio LuostarinenSimopekka VänskäHeljä-Marja SurcelHelena FaustJoakim DillnerMatti LehtinenPublished in: PLoS medicine (2021)
ClinicalTrials.gov number NCT00534638, https://clinicaltrials.gov/ct2/show/NCT00534638.